A proneurogenic, neuroprotective chemical that preserves newly created brain cells and boosts learning and memory in animal studies. The discovery could have implications for developing treatments of neuropsychiatric and neurodegenerative diseases. These include schizophrenia, major depression, bipolar disorder, normal aging, epilepsy, traumatic brain injury, post-traumatic stress disorder, Parkinson's disease, Alzheimer's disease, Down syndrome, spinocerebellar ataxia, amyotrophic lateral sclerosis, Huntington's disease, stroke, radiation therapy, chronic stress, and abuse of neuro-active drugs, such as alcohol, opiates, methamphetamine, phencyclidine, and cocaine.    



2M BioTech partners with research groups, universities, inventors, and early stage biotech firms to accelerate the commercialization of their products and technologies.  2M BioTech provides an alternative to the traditional models associated with university-based technology licensing offices and venture capital financing.